Clinical Trial Update: the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients

View source ↗

Summary

An update on a clinical trial evaluating the effect of human chorionic gonadotropin (hCG) treatment as a cardiovascular morbidity factor in patients with Primar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Human chorionic gonadotropin (human chorionic gonadotropin)

Snippet

Sponsor: Meir Medical Center | Conditions: Primary Sjogren Syndrome With Multisystem Involvement | Status: UNKNOWN